This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: East China University of Science and Technology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations in Stem Cell Treatment by Inventor Kai Dai
Introduction
Kai Dai is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of stem cell research, particularly in the treatment of hematopoietic damage. His innovative work has the potential to transform medical practices related to bone marrow failure and leukemia.
Latest Patents
Kai Dai holds a patent for the "Use of stem cells produced by stem cell generator in treatment of hematopoietic damage." This patent discloses a stem cell generator designed for the generation of organoids after the development of biological materials loaded with active substances. These substances include mesenchymal stem cells, bone morphogenetic proteins, and other growth factors that induce bone regeneration. The stem cell generator contains various types of blood cells and hematopoietic progenitor/stem cells, which are essential for treating conditions such as bone marrow failure and leukemia caused by radiotherapy or chemotherapy.
Career Highlights
Kai Dai is affiliated with the East China University of Science and Technology, where he continues to advance his research in stem cell technology. His work is recognized for its potential impact on regenerative medicine and the treatment of serious health conditions.
Collaborations
Some of his notable coworkers include Changsheng Liu and Jing Wang, who contribute to the collaborative efforts in their research projects.
Conclusion
Kai Dai's innovative work in stem cell treatment showcases the potential of scientific advancements in addressing critical health issues. His contributions are paving the way for future developments in regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile